adenosine monophosphate has been researched along with Atrial Fibrillation in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bistrovic, P; Jordan, A; Lucijanic, M; Manola, S; Ortner Hadziabdic, M; Papic, I | 1 |
1 other study(ies) available for adenosine monophosphate and Atrial Fibrillation
| Article | Year |
|---|---|
Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Atrial Fibrillation; COVID-19 Drug Treatment; Humans | 2022 |